Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia (HAB)

Herrmann Apparatebau

Status: Terminated

Conditions: Hypertonia

Study type: Observational

Funder types: Industry

Identifiers

NCT01902602

HAB10-2012

Details and patient eligibility

About

The objective of this clinical study is to evaluate the influence of the Great autohemotherapy with oxygen-ozone (hyperbaric ozone therapy ) to describe the cardiovascular system in patients with resistant hypertension. The primary endpoint is the change in mean blood pressure after 10 treatments .

In addition, data are collected on the immune system as well as for food and sleep quality.

Enrollment: 19 patients

Sex: All

Ages: 45+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Resistant Hypertension > 140 / > 90mmHg
• Inclusion age : 45 +
• Regular monitoring of blood levels considered
• pre-medication to lower blood pressure for at least 3 weeks before the preliminary investigation consistent
• Men and Women

Exclusion criteria

• derailed diabetes
• renal impairment , renal creatinine clear <50 ml
• Non - austherapierte cancer / tumor patients
• Non - adjusted thyroid dysfunction
• BMI> 35
• LVEF <limit ( " 35% " )
• Peripheral AVK ( ABI - measurement ) > Stage II
• regurgitation > Stage I
• abdominal aneurysm
• infections
• acute febrile infections with temperature > 38.5 ° C
• COPD and asthma to stage III
• dyspnea NYHA > Stage III
• z.n. Stroke shorter than 12 weeks
• Acute liver failure
• Acute Apoplexy
• Severe poisoning
• drug addiction
• hyperthyroidism
• Hypotension
• hypocalcemia
• hypoglycemia
• ozone allergy
• pregnancy
• clotting problems ( hemophilia )
• pre-existing condition with hemoglobin < 9mg/dl
• Fresh myocardial infarction
• Internal bleeding
• thrombocytopenia
• Acute alcohol
• Citrus allergy when using sodium citrate